AstraZeneca’s Farxiga Authorized Generic Aims To Broaden Access As Medicare Price Cut Looms

The authorized generic also could mitigate the impact of eliminating the cap on Medicaid price inflation rebates, which went into effect in January.

US Farxiga Sales were Up 61% In the First Quarter and 'Benefitted' from the Authorized Generic. • Source: Shutterstock

More from Pricing Debate

More from Market Access